Recent Updates
Recently added Catalysts
TMDX Negative Sentiment

TransMedics Group, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – TMDX

Key Takeaway: TransMedics Group, Inc. is facing a class action securities lawsuit led by Levi & Korsinsky, LLP. The lawsuit accuses the company of severe misconduct, including allegations of using kickbacks and fraudulent practices to boost revenue while concealing safety issues. Investors who suffered losses from February 28, 2023, to January 10, 2025, are encouraged to seek compensation. The firm emphasizes that participation has no costs for affected investors.
Price reaction · baseline $69.33 (2025-03-03 close) · hit after-hours · 3 other TMDX headline(s) in the window, move may be shared
day 0 close
-0.3%

Market Sentiment Analysis

CONCERNS & RISKS

  • The lawsuit alleges TransMedics engaged in securities fraud.
  • The company is accused of using kickbacks and fraudulent overbilling.
  • There are claims of unsafe practices and lack of safety oversight.
  • Statements from the company regarding its operations and prospects are deemed materially false and misleading.

Full Press Release Details

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of TransMedics investors who were adversely affected by alleged securities fraud between February 28, 2023 and January 10, 2025. Follow the link below to get more information and be contacted by a member of our team:
TMDX investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
WHAT'S NEXT? If you suffered a loss in TransMedics during the relevant time frame, you have until April 15, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 17th Floor

Frequently Asked Questions

What is the class action lawsuit against TransMedics?

The lawsuit seeks to recover losses for investors due to alleged securities fraud from February 28, 2023, to January 10, 2025.

What allegations are made against TransMedics?

The complaint alleges TransMedics used kickbacks, engaged in unsafe practices, and made misleading statements about its operations.

What is the deadline to join the lawsuit?

Investors have until April 15, 2025, to request appointment as lead plaintiff.

Is there a cost to participate in the class action?

There are no out-of-pocket costs or fees for class members to participate.

Why choose Levi & Korsinsky for this lawsuit?

Levi & Korsinsky has secured hundreds of millions for shareholders and is a top-ranking firm in securities litigation.

Last updated: Mar 4, 2025